Extendicare Inc. (TSE:EXE – Get Free Report) shares rose 11.5% on Wednesday . The company traded as high as C$17.78 and last traded at C$17.78. Approximately 194,920 shares traded hands during trading, an increase of 9% from the average daily volume of 178,940 shares. The stock had previously closed at C$15.94.
Analysts Set New Price Targets
Several analysts recently issued reports on the stock. Cibc World Mkts upgraded shares of Extendicare to a “strong-buy” rating in a research report on Monday, September 22nd. National Bankshares lifted their target price on Extendicare from C$16.10 to C$17.50 and gave the stock an “outperform” rating in a report on Wednesday, October 8th. National Bank Financial raised shares of Extendicare to a “strong-buy” rating in a report on Wednesday, July 16th. Finally, CIBC set a C$18.00 target price on shares of Extendicare and gave the stock an “outperform” rating in a report on Monday, September 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, Extendicare has an average rating of “Moderate Buy” and a consensus target price of C$15.20.
Check Out Our Latest Research Report on Extendicare
Extendicare Trading Up 12.0%
Extendicare Dividend Announcement
The company also recently announced a monthly dividend, which will be paid on Monday, November 17th. Stockholders of record on Monday, November 17th will be given a $0.042 dividend. This represents a c) annualized dividend and a dividend yield of 2.8%. The ex-dividend date is Friday, October 31st. Extendicare’s dividend payout ratio (DPR) is 50.57%.
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Stories
- Five stocks we like better than Extendicare
- The Most Important Warren Buffett Stock for Investors: His Own
- Papa John’s $2.7 Billion Takeover Bid: A Price on Untapped Value
- Technology Stocks Explained: Here’s What to Know About Tech
- Is Qualcomm Up 40% or Down 20%? 2 Contrarian Takes
- How to Calculate Return on Investment (ROI)
- Guardian Pharmacy Stock Pops on Q3 Strength and Upbeat Forecast
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
